文献速递产科母胎医学

妊娠期及产后女性体外膜氧合:十年病例系列

Extracorporeal membrane oxygenation in pregnant and postpartum women: a ten-year case series.
PubMed 文献 · Am J Obstet Gynecol MFM · 2020-03-25

单中心十年病例系列纳入9例妊娠或产后6周内启动ECMO的女性,母亲总生存率33%;妊娠期或分娩时启动者母胎生存率60%,产后启动的4例母亲均未存活。

要点

  • 妊娠或分娩时启动ECMO者母胎生存率60%,支持其作为挽救治疗。
  • 产后启动ECMO的4例母亲均未存活。
  • 最常见指征为急性呼吸窘迫综合征(7例,78%)。

核心结论

  • 妊娠期或分娩时启动ECMO时60%的母亲和胎儿存活,支持当前将ECMO作为妊娠期及产时女性的挽救治疗。
  • 作者认为ECMO有潜力提高母婴生存率,应被视为围产期可逆性心肺衰竭女性的挽救治疗。

研究设计与样本

  • 单中心病例系列,检索2008年1月1日至2017年12月31日期间接受ECMO的14-44岁育龄女性,手动审查病历纳入ECMO启动时妊娠或产后<6周者,描述临床特征及母婴结局。

主要发现

  • 54例育龄女性接受ECMO,其中9例(17%)为妊娠或产后<6周:产前4例、剖宫产术中1例、产后4例(含产后第0或1天启动2例)。
  • 母亲总生存率为33%。
  • 最常见指征为急性呼吸窘迫综合征,7例(78%),其中5例为感染性病因、2例归因于子痫前期。
  • ECMO中位天数6天(范围1-14天),无产科出血病例;除1例外均使用静脉-静脉ECMO。
  • 妊娠期启动ECMO的4例孕周分别为21、22、29、30周,母亲生存率50%、胎儿死亡率50%;产后启动的4例母亲均未存活。

关键数值与推荐

  • 妊娠期或分娩时启动ECMO者母胎生存率60%。
  • 未妊娠但接受ECMO的45例育龄女性中23例(51%)存活。
  • 作者发现ECMO在机械通气后尽早、疾病早期启动者生存倾向。

临床怎么用

  • 作者认为ECMO应被视为围产期可逆性心肺衰竭女性的挽救治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: tExtracorporeal membrane oxygenation (ECMO) is a life-saving therapy for severe, reversible cardiopulmonary failure, but data regarding its use in pregnancy and the postpartum period are limited. We sought to quantify survival of pregnant and postpartum women necessitating ECMO in a contemporary cohort at a single tertiary institution. STUDY DESIGN: All women of reproductive age (14-44 years), who underwent ECMO at our institution between January 1, 2008, and December 31, 2017, were identified using a query of hospital encounters for ECMO-related CPT codes. We manually reviewed all charts of women of reproductive age; women who were pregnant or <6 weeks postpartum at the time of ECMO initiation were included. Clinical characteristics and maternal and fetal outcomes are described. RESULTS: In this study, 54 women of reproductive age underwent ECMO for cardiopulmonary failure. Of those, 9 (17%) were pregnant or <6 weeks postpartum at the time of ECMO initiation: 4 antepartum, 1 intraoperative at the time of cesarean delivery, and 4 postpartum (including 2 in whom ECMO was initiated on postpartum day 0 or 1). Overall, maternal survival was 33%. The median maternal age was 24 years (range 19-39 years); most women were nonsmokers without underlying medical comorbidities. The most common indication for ECMO use in pregnant and postpartum women was acute respiratory distress syndrome, which was present in 7 cases (78%), including 5 cases that were due to infectious etiologies and 2 cases that were attributed to preeclampsia. The median number of days on ECMO was 6 (range 1-14). There were no cases of obstetric hemorrhage. Venovenous ECMO was utilized in all but 1 case, in which emergent attempted venoarterial ECMO was unsuccessful in resuscitating a postpartum patient with cardiac arrest and a massive pulmonary embolism. A total of 4 women were initiated on ECMO during pregnancy: their gestational ages at ECMO initiation were 21, 22, 29, and 30 weeks; maternal survival was 50%, and fetal mortality was 50%. A case of ECMO initiated during cesarean section at 29 weeks' gestation resulted in both maternal and fetal survival. Among 4 mothers with ECMO initiation after childbirth, none survived. Finally, we found a tendency toward survival in those patients for whom ECMO was initiated soon after mechanical ventilation, earlier in the disease process. In contrast, in this study, 23 of 45 women of reproductive age (51%) who were not pregnant but underwent ECMO survived. CONCLUSION: When ECMO was initiated during pregnancy or during childbirth, 60% of mothers and fetuses survived, supporting current use of ECMO as a salvage therapy in pregnant and intrapartum women. In this generally young and healthy population, ECMO has the potential to increase the survival rates of both mother and fetus and should be considered a salvage therapy for peripartum women with reversible forms of cardiorespiratory failure.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Webster CM, Smith KA, Manuck TA, et al. Extracorporeal membrane oxygenation in pregnant and postpartum women: a ten-year case series. Am J Obstet Gynecol MFM. 2020. PMID: 32835205. doi:10.1016/j.ajogmf.2020.100108

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。